盐酸帕罗西汀对难治性肠易激综合征疗效的影响

Abstract
Figure/Table
References
Related Citation (5)

Download: PDF (607 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To study the clinical therapeutic effect of paroxetine hydrochloride on refractory irritable bowel syndrome. Methods 124 patients with refractory irritable bowel syndrome , were randomly divided into conventional group (62 cases,receiving oral trimebutine maleate 0.1 g, 3/d and bifidobacteria capsules 420 mg, 3/d) and paroxetine group (62 cases, in addition to conventional treatment, oral paroxetine hydrochloride 20 mg, 1/d ).The course of treatment was 4 weeks for both groups.Before and after treatment , the Self-rating Anxiety Scale (SAS) and the Self-rating Depression Scale (SDS) were used for assessment.Symptom improvement and efficiency in the two groups after treatment were observed. Results In the paroxetine group, the total effective rate was 96.77% and 77.42% in the conventional group, with a significant difference(P<0.01) between the two groups. The SAS and SDS scores after and before treatment in the paroxetine groups were significantly different (P<0.01), SAS and SDS scores were not significantly different (P>0.05) in the conventional group before and after treatment.The SAS and SDS scores before treatment were significantly different between patients with irritable bowel syndrome and normal group (P<0.01).Conclusions Paroxetine hydrochloride in treatment of refractory irritable bowel syndrome is significantly efficient and can improve the patient's emotional state.

Received: 25 July 2011

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2012/V23/I1/7

［1］	蔡淦，张正利. 肠易激综合征研究现状与展望［J］.世界华人消化杂志，2005，13(8)：937-939.
［1］	蔡淦，张正利. 肠易激综合征研究现状与展望［J］.世界华人消化杂志，2005，13(8)：937-939.
[2]	樊宇靖，陈淑洁，姒健敏.多塞平(71例)与胰酶(32例)治疗肠易激综合征的比较［J］.中国新药与临床杂志，2004，23(2)：79-82.
[2]	樊宇靖，陈淑洁，姒健敏.多塞平(71例)与胰酶(32例)治疗肠易激综合征的比较［J］.中国新药与临床杂志，2004，23(2)：79-82.
[3]	张明圆. 精神科评定量表手册［M］.2版，长沙：湖南科学技术出版社，1998：16.
[3]	张明圆. 精神科评定量表手册［M］.2版，长沙：湖南科学技术出版社，1998：16.
[4]	Hu W H. Wong W M, Lam C L, et al. Anxiety but not depression determines health care-secking behaviour in Chinese with dyspresin and irritable bowel syndrome:apopulation-bases study［J］.Aliment Pharmacol Ther, 2002，16(2)：2081-2088.
[4]	Hu W H. Wong W M, Lam C L, et al. Anxiety but not depression determines health care-secking behaviour in Chinese with dyspresin and irritable bowel syndrome:apopulation-bases study［J］.Aliment Pharmacol Ther, 2002，16(2)：2081-2088.
[5]	潘国宗，鲁素影.北京地区肠易激综合症的流行学研究：一个整群、分层、随机的调查［J］.中华流行病学杂志，2002，22（10）：637-638.
[5]	潘国宗，鲁素影.北京地区肠易激综合症的流行学研究：一个整群、分层、随机的调查［J］.中华流行病学杂志，2002，22（10）：637-638.
[6]	李敬阳. 综合性治疗功能性消化不良的临床观察［J］.中国心理卫生杂志，2004，18(6)：432-434.
[6]	李敬阳. 综合性治疗功能性消化不良的临床观察［J］.中国心理卫生杂志，2004，18(6)：432-434.
[7]	张卫卫，李岩. 精神、心理因素与功能性胃肠病［J］.世界华人消化杂志，2002，10（11）：1324-1328.
[7]	张卫卫，李岩. 精神、心理因素与功能性胃肠病［J］.世界华人消化杂志，2002，10（11）：1324-1328.
[8]	潘国宗.神经机制在肠易激综合征发病中的作用［J］.胃肠病学和肝病学杂志，2002，11（4）：289-292.
[8]	潘国宗.神经机制在肠易激综合征发病中的作用［J］.胃肠病学和肝病学杂志，2002，11（4）：289-292.
[9]	雷景根. 盐酸帕罗西汀治疗肠易激综合征34例临床观察［J］.浙江预防医学，2006，18（8）：66-67.
[9]	雷景根. 盐酸帕罗西汀治疗肠易激综合征34例临床观察［J］.浙江预防医学，2006，18（8）：66-67.
[10]	文彬，韩伟.选择性5-羟色胺再摄取抑制剂治疗抑郁症的应用现状［J］.中国临床康复，2004，8(15)：2952-2953.
[10]	文彬，韩伟.选择性5-羟色胺再摄取抑制剂治疗抑郁症的应用现状［J］.中国临床康复，2004，8(15)：2952-2953.